Human DNA damage-inducible transcript 4 protein(DDIT4) ELISA kit

Code CSB-EL006590HU
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
DNA-damage-inducible transcript 4
Alternative Names
DDIT4 ELISA Kit; DDIT4_HUMAN ELISA Kit; Dig2 ELISA Kit; DNA damage inducible transcript 4 ELISA Kit; DNA damage inducible transcript 4 protein ELISA Kit; DNA damage-inducible transcript 4 protein ELISA Kit; FLJ20500 ELISA Kit; HIF 1 responsive protein RTP801 ELISA Kit; HIF 1 responsive RTP801 ELISA Kit; HIF-1 responsive protein RTP801 ELISA Kit; Protein regulated in development and DNA damage response 1 ELISA Kit; REDD-1 ELISA Kit; REDD1 ELISA Kit; RTP801 ELISA Kit
Abbreviation
DDIT4
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, tissue homogenates, cell lysates, urine, cerebrospinal fluid (CSF)
Detection Range
0.156 ng/mL-10 ng/mL
Sensitivity
0.039 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Cancer
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human DDIT4 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
 SampleSerum(n=4)
1:1Average %89
Range %86-92
1:2Average %94
Range %89-98
1:4Average %96
Range %92-99
1:8Average %98
Range %92-103
Recovery
The recovery of human DDIT4 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample TypeAverage % RecoveryRange
Serum (n=5) 9489-99
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/mlOD1OD2AverageCorrected
102.948 2.754 2.851 2.691
52.539 2.412 2.476 2.316
2.51.781 1.662 1.722 1.562
1.251.248 1.198 1.223 1.063
0.6250.738 0.706 0.722 0.562
0.3120.514 0.504 0.509 0.349
0.1560.305 0.298 0.302 0.142
00.162 0.158 0.160  
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human DDIT4 ELISA Kit was designed for the quantitative measurement of Human DDIT4 protein in serum, tissue homogenates, cell lysates, urine, cerebrospinal fluid (CSF). It is a Sandwich ELISA kit, its detection range is 0.156 ng/mL-10 ng/mL and the sensitivity is 0.039 ng/mL .

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
Regulates cell growth, proliferation and survival via inhibition of the activity of the mammalian target of rapamycin complex 1 (mTORC1). Inhibition of mTORC1 is mediated by a pathway that involves DDIT4/REDD1, AKT1, the TSC1-TSC2 complex and the GTPase RHEB. Plays an important role in responses to cellular energy levels and cellular stress, including responses to hypoxia and DNA damage. Regulates p53/TP53-mediated apoptosis in response to DNA damage via its effect on mTORC1 activity. Its role in the response to hypoxia depends on the cell type; it mediates mTORC1 inhibition in fibroblasts and thymocytes, but not in hepatocytes. Required for mTORC1-mediated defense against viral protein synthesis and virus replication. Inhibits neuronal differentiation and neurite outgrowth mediated by NGF via its effect on mTORC1 activity. Required for normal neuron migration during embryonic brain development. Plays a role in neuronal cell death.
Gene References into Functions
  1. DDIT4 might serve as a novel prognostic biomarker in several malignancies. PMID: 28484222
  2. Cellular metabolism constrains innate immune responses in preterm infants due to perturbations in the expression of PPARgamma, MALT1, DDIT4, and most of the cytokines. PMID: 30446641
  3. these findings uncover a novel mechanism by which PML loss may contribute to mTOR activation and cancer progression via dysregulation of basal DDIT4 gene expression. PMID: 28332630
  4. A microarray analysis revealed that in A3G-transduced Vero cells, several cellular transcripts were differentially expressed, suggesting that A3G regulates the expression of host factors. One of the most upregulated host cell factors, REDD1 (regulated in development and DNA damage response-1, also called DDIT4), reduced MV replication approximately 10-fold upon overexpression in Vero cells. PMID: 29925665
  5. This is concurrent with an increase in the expression level of DDIT4, which is an inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway. these results provided a novel insight on miR1243p involvement in the biological alterations of male patients with major depressive disorder and suggested that this miRNA may also serve as a malespeci fi c target for antidepressant treatment PMID: 29115444
  6. DDIT4 activity is directly linked to regulation of mTOR signalling PMID: 27876894
  7. The HIF-1alpha-REDD1-mTOR pathway was involved in the response to hypoxia in BeWo cells. Hypoxia-induced REDD1 upregulation is mediated by a HIF-1alpha-dependent pathway. Disruption of REDD1 blocked the effects of hypoxia on suppressing mTOR and resulted in additional accumulation of HIF-1alpha in BeWo cells. PMID: 27577706
  8. REDD1 is overexpressed during Familial Mediterranean fever inflammatory attacks induced by physical or psychological stress PMID: 28342915
  9. Expression of key autophagy markers (microtubule-associated protein 1A/1B light chain 3 and autophagy protein 5) was markedly reduced in cultured human chondrocytes with REDD1 depletion. PMID: 28334504
  10. The production of superoxide anion in nockout-Rtp801 mouse lung fibroblasts (MLF) was lower than that in Rtp801 Wt cells after cigarette smoke extract treatment, and it was inhibited in Wt MLF by silencing nicotinamide adenine dinucleotide phosphate oxidase-4 (Nox4) expression with small interfering Nox4 RNA. PMID: 27556956
  11. Changes in REDD1 mRNA and protein have been observed in skeletal muscle under various physiological conditions (e.g., nutrient consumption and resistance exercise) and pathological conditions (e.g., sepsis, alcoholism, diabetes, obesity) suggesting a role for REDD1 in regulating mTORC1-dependent skeletal muscle protein metabolism. [Review] PMID: 27189933
  12. a novel STAT3-dependent mechanism of both IL-6-induced activation of mTOR and IL-6-dependent reversion of stress-induced inhibition of mTOR activity, is reported. PMID: 27094713
  13. findings implicate REDD1 as a crucial regulator of mTORC1 activity in iron-depleted cells PMID: 26827808
  14. C/EBPbeta promotes autophagy in PC3 cells by augmenting REDD1 expression. PMID: 26968249
  15. These data highlight the central role of REDD1 in regulating both protein synthesis and autophagy in skeletal muscle during sepsis. PMID: 26487002
  16. Findings from this study propose a REDD1-regulated mechanism in T2D skeletal muscle that may contribute to whole body insulin resistance and may be a target to improve insulin action in insulin-resistant individuals. PMID: 26269521
  17. REDD1 knockout (KO) mice, all skin compartments, epidermal stem, and progenitor cells were protected from atrophic effects of glucocorticoids. PMID: 25504525
  18. MiR-630 reduced apoptosis by downregulating several apoptotic modulators, PARP3, DDIT4, and EP300. PMID: 25255219
  19. REDD1 and p-AKT over-expression may serve as a prognostic biomarker in ovarian cancer, but KRAS mutations and REDD1 protein over-expression were not correlated in OC. PMID: 25337238
  20. Caspase 3 cleaved REDD1 during apoptotic activation. PMID: 25058423
  21. the results demonstrate that REDD1 acts not only as a repressor of mTORC1 but also as a constant modulator of the phosphorylation of Akt in response to growth factors and nutrients. PMID: 25056877
  22. analysis of ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1 PMID: 25147182
  23. Translocation to the plasma membrane appears to be an inactivation mechanism of REDD1 by G-protein coupled receptors. PMID: 24338366
  24. these postmortem and preclinical findings identify REDD1 as a critical mediator of the atrophy of neurons and depressive behavior caused by chronic stress exposure PMID: 24728411
  25. REDD1 expression plays a role in maintaining normal function of placenta, while the increase of REDD1 is related to the pathogenesis of pre-eclampsia. PMID: 22527987
  26. mTORC1 regulates REDD1 protein stability in a 26S proteasome dependent manner. PMID: 23717519
  27. The sustained overexpression of Redd1 leads to mTORC1 inhibition and to consequent Akt activation that is involved in cell survival. PMID: 23528835
  28. An immobilization-induced attenuation of mTORC1 signaling mediated by induction of REDD1/2 and defective p70S6K1 phosphorylation. PMID: 23193052
  29. mechanisms have evolved in tumors to escape growth suppressive signals resulting from VHL loss and REDD1 upregulation PMID: 21798997
  30. REDD1 is a new host defense factor, and chemical activation of REDD1 expression represents a potent antiviral intervention strategy PMID: 21909097
  31. these results collectively demonstrate that TXNIP stabilizes Redd1 protein induced by ATF4 in response to 2-DG, resulting in potentiation of mTOR suppression. PMID: 21460850
  32. Metformin increases REDD1 expression in a p53-dependent manner. REDD1 invalidation, using siRNA or REDD1(-/-) cells, abrogates metformin inhibition of mTOR. PMID: 21540236
  33. Data show that miR-495 expression was directly modulated by transcription factor E12/E47, and promotes oncogenesis via downregulation of E-cadherin and REDD1. PMID: 21258409
  34. these results provide preliminary evidence that Redd1 inhibits the invasive activity of NSCLC cells via suppression of the mTOR downstream pathway. PMID: 21414293
  35. DDIT4, an inhibitor of mTOR signaling, is a direct target for 1,25(OH)(2)D(3) and VDRE-BP, and functions to suppress cell proliferation in response to vitamin D PMID: 21123297
  36. In the HER2 overexpression type and triple-negative breast carcer, tumor cell proliferation and survival in the hypoxic tumor environment could possibly be due to disinhibition of the mTOR pathway and HIF-1alpha stabilization by downregulation of REDD1. PMID: 21266827
  37. Our data support the notion that Rtp801 may represent a major molecular sensor and mediator of cigarette smoke-induced lung injury. PMID: 20473305
  38. PKR represents a cognitive decline biomarker able to dysregulate translation via two consecutive targets p53 and Redd1 in Alzheimer disease lymphocytes PMID: 19210572
  39. that expression of RTP801 was lower in oral lichen planus than in controls PMID: 20374513
  40. sertraline exerts antiproliferative activity by targeting the mTOR signaling pathway in a REDD1-dependent manner PMID: 20354178
  41. Structure/function analyses have led us to identify two segments in REDD1 that are essential for mTORC1 inhibition. PMID: 20166753
  42. Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. PMID: 19996311
  43. RTP801 might play important roles in Abeta toxicity and the pathogenesis of Alzheimer's disease PMID: 14646594
  44. co-transfection with antisense Sp1 oligonucleotide suggests that hypoxia induction of the RTP801 promoter is mediated by Sp1 PMID: 15180327
  45. REDD1 (RTP801) can act as a transcriptional downstream target of PI 3-kinase signaling in human prostate cancer cells. PMID: 15592522
  46. RTP801 and RTP801L work downstream of AKT and upstream of TSC2 to inhibit mTOR functions PMID: 15632201
  47. REDD1 as a critical transducer of the cellular response to energy depletion through the TSC-mTOR pathway. PMID: 15988001
  48. Stress response gene REDD1 is identified in this review as an essential regulator of checkpoint kinase mTOR activity through the tuberous sclerosis tumor suppressors TSC1/2 complex. PMID: 16258273
  49. The elevation of RTP801 we detect in PD substantia nigral neurons may mediate their degeneration. PMID: 17005863
  50. These results demonstrate that hypoxic condition-and high cell density-induced expression of Redd1 is mediated by coactivation of Sp1 and HIF-1alpha downstream of the PI3K/Akt signaling pathway. PMID: 17307335

Show More

Hide All

Subcellular Location
Mitochondrion. Cytoplasm, cytosol.
Protein Families
DDIT4 family
Tissue Specificity
Broadly expressed, with lowest levels in brain, skeletal muscle and intestine. Up-regulated in substantia nigra neurons from Parkinson disease patients (at protein level).
Database Links

HGNC: 24944

OMIM: 607729

KEGG: hsa:54541

STRING: 9606.ENSP00000307305

UniGene: Hs.744875

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1